Product Specification
MW: ~43kDa (before lipidation)
Purity: ≥95% (SDS-PAGE)
Formulation: Lyophilized. In 100 μl 50mM TRIS-HCl, pH 7.6, containing 100mM sodium chloride, with 200mM mannitol.
Source/Host: Produced in insect cells. Recombinant full length human tissue factor (TF).
Reconstitution: Reconstitute with 100 µl deionized water.
Application: Useful for studying the clotting cascade or for screening Factor VIIa inhibitors. Use in equimolar amounts as a cofactor with Factor VIIa (Prod. No. BML-SE438) when using a peptide (such as BML-P199) or Factor X as a Factor VIIa substrate.
Shipping: SHIPPED ON BLUE ICE
Long Term Storage: +4°C
Handling: After reconstitution, prepare aliquots and store at -80°C.
Avoid freeze/thaw cycles.
Recombinant full-length human tissue factor, lipidated in phosphatidylcholine/phosphatidylserine vesicles. Tissue factor (CD142) is the initiator of the extrinsic clotting pathway, but also plays roles in numerous processes, such as tumor progression, inflammation, and cell adhesion. In the clotting pathway, Factor VIIa only has full activity when complexed with lipidated tissue factor.

TissueFactor(lipidated)(human)(recombinant)信息由上海叶舟生物科技有限公司为您提供，如您想了解更多关于TissueFactor(lipidated)(human)(recombinant)报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途